Adeshwar Meditex board to meet on May 21 for FY26 results
Adeshwar Meditex Limited will hold a board meeting on May 21, 2026, to approve audited financial results for the year and half-year ended March 31, 2026. The board will also note the internal audit report and the resignation of an independent director. The trading window is closed from April 1 until 48 hours post-results announcement.

*this image is generated using AI for illustrative purposes only.
adeshwar meditex has announced that its board of directors will meet on Thursday, May 21, 2026, through video conferencing. The primary agenda for the meeting is to consider and approve the standalone audited financial results for the half year and financial year ended March 31, 2026.
Agenda Details
In addition to the financial results, the board will take note of the internal audit report for the financial year ended March 31, 2026. The directors will also acknowledge the resignation of Mr. Arun Koli from the post of Independent Director of the company. Any other matter with the permission of the Chair may also be discussed during the meeting.
Trading Window Closure
Pursuant to SEBI regulations, the trading window for the company's securities has been closed since April 1, 2026. This closure will remain in effect until 48 hours after the announcement of the financial results on May 21, 2026. During this period, designated persons, including promoters, directors, connected persons, insiders, and their immediate relatives, are prohibited from trading in the company's shares or securities.
Compliance
The intimation regarding the board meeting has been submitted to BSE Limited in compliance with Regulation 29 and/or 33 of the SEBI (LODR) Regulations, 2015. The company has scrip code 543309 and scrip ID ADESHWAR on the exchange.
How might Adeshwar Meditex's audited financial results for FY2026 compare to the previous year, and what revenue or profitability trends could emerge from the medtech sector?
Who is likely to succeed Mr. Arun Koli as Independent Director, and how could the change in board composition affect corporate governance and investor confidence?
Could the resignation of an Independent Director signal any underlying strategic shifts or challenges within Adeshwar Meditex's leadership structure?































